falls within therangereported by Valentine et al., who used atomic absorption spectrophotometry (13). Othershave reported values that differ somewhatfrom ours: 25 g/L (9); 42 range0-69 (14); and 34 (SD 24) g/L, range
possible aetiological roleinthesudden death ininfants syndrome.
N.Z. Med. J. 71, 32-34 (1970).
7. Shamberger, R. J., and Willis, C. E., Selenium distribution and human cancer mortality. CRC Crit. Rev. Clin. Lab. Sd. 2,211-221 (1971). 8 . Wikstrom, J. T., and Westermarck, P. J., Selenium, vitamin E and copper in multiple sclerosis. Acta Neurol. Scand. 54, 287-290 (1976 is commonly used in routine laboratory work for measuring cortisol in plasma. As compared with other methods, such as fluorometry, RIA also has a relatively high selectivity; however, there is some cross reaction with other steroids-e.g., cortisol metabolitesand syntheticcorticosteroids, which may become important in the diseased state and during drug treatment (1 ). 3 Gas chromatography/mass spectrometry (GCMS) withselected-ion monitoringisrecognized as one of the most selective analytical techniques available today and has been suggested as a "definitive" method in clinical chemistry (2) . Bj#{246}rkhem et al. (3) described a GCMS method with electron-impact ionization for the determination of plasma cortisol. Cortisol labeled with 14Cwas originally used as internal standard, but has recently been replaced with a deuterium-labeled analog (4). We present here a modified method based on chemical-ionization (CI) GCMS, which we used to measure cortisol in plasma and urine during an investigation of the systemic effects of glucocorticoid ointments. We used RIA to rapidly check if plasma cortisol suppression was severe, in which case the steroid treatment was discontinued. For the fmal evaluation of cortisol concentrations, the same plasma samples were analyzed at a later date by the more laborious GCMS method. The data compared are those for 395 plasma samples from 16 healthy men. Blood (10 mL) was drawn at 0800 hours and collected in heparinized Venoject tubes (Terumo Corp., Tokyo, Japan). After centrifugation, 2.00 mL of plasma was added to a glass tube and stored at -20 #{176}C until analysis by GCMS. Another 0.5 mL was transferred to another tube for immediate analysis by RIA. Blood was collected on 15-30 occasions from each subject during a period of three months. Twenty-four-hour urine specimens were collected for the determination of free cortisol by GCMS. The design of the study is described in detail elsewhere (5).
Reagents.
[2H3JCortisol ([9,12,12-2H3] 11f3,l7cx,21-trihydroxy-4-pregnene-3,20-dione) was obtained from KOR Isotopes, Cambridge, MA 02142; trimethylsilylimidazole from E. Merck, Darmstadt, F.R.G.; and methoxyamine hydrochloride from Supelco, Bellefonte, PA 16823. Pyridine, hexane, and dichloromethane were of analytical grade and used without further purification.
A kit for radioimmunoassay of plasma cortisol (RIANEN Cortisol [1251]) was obtained from New England Nuclear, North Billerica, MA 01862.
Apparatus.
The mass spectrometer (Model 4000; Finnigan Corp., Sunnyvale, CA 94086) was operated in the CI mode and interfaced to a Finnigan 6100 data system (revision I software). The GC column (40 cm X 2 mm i.d.) was packed with 1% OV-1 on Gas Chrom Q, 100-120 mesh, and connected to the mass spectrometer via the direct transfer line. Helium was used as carrier gas at a flow rate of 25 mL/min. The CI reagent gas (ammonia) was added as make-up gas to the GC effluent to give an indicated ion source pressure of 67 Pa (0.5 Torr) and a pressure of 7.3 X 10 Pa (5.5 X 10 Torr) in the analyzer region. The temperatures of the injection block, GC oven, transfer line, and ion source were 260, 240, 250, and 250 #{176}C, respectively.
The ion source was operated at an ionizing energy of 125 eV and an emission current of 0.25 mA. During selected-ion monitoring the instrument was set by the data system to measure m/z 637 and 640.
To quantitate the bound tracer in the radioimmunoassay, we used an LKB-Wallac 80 000 gamma sample counter (LKB, 16126 Bromma, Sweden).
GCMS assay. The extraction and derivatization procedure of Bj#{246}rkhem et a!. add 25 sL of tnmethylsilylimidazole, and heat the mixture at 100 #{176}C for 30 mm. Allow the reaction vial to cool, then add 50 L of hexane and shake the vial so that the two phases are thoroughly mixed. Use about 4 zL of the hexane phase for GCMS analysis. The retention time of the dimethoximetnis(trimethylsilyl) derivative of cortisol is about 0.8 mm.
Samples for the standard curve were prepared by adding known amounts of cortisol to 2.0 mL of water, corresponding to concentrations of 50-600 nmol/L. The samples were then taken through the complete analytical procedure. A complete standard curve was prepared every day.
Precision studies were performed by taking replicate samples, either from urine and plasma containing normal Radioimmunoassay.
In the RIANEN Cortisol [1251] kit, 10 tL of plasma is used. Separation of the bound from the free antigen involves use of a prereacted first-and second-antibody complex. After a 30-mm incubation followed by centrifugation, the supernate is discarded and the radioactivity of the pellet containing the bound tracer is counted with a gamma counter. The standard curve covers the range 55-1380 nmol/L, and values of the unknowns are obtained by interpolation.
Results and Discussion
The method described by Bj#{246}rkhem et al. (3) for plasma cortisol determination with electron-impact-GCMS shows selectivity and sufficient sensitivity. Our mass spectrometer, however, is operated most of the time in the CI mode, and we find that a few days of CI operation drastically reduces the sensitivity of the instrument in the electron-impact mode. Therefore, we needed a method based on CI-GCMS for the analysis of cortisol. Figure 1 shows the CI mass spectrum of the dimethoximetnis(trimethylsilyl) derivative of cortisol when ammonia was used as the reagent gas. The protonated molecular ions (m/z 637 and 640) of cortisol and the deuterium-labeled internal standard, respectively, were used for selected-ion monitoring. Figure 2 shows a selected-ion current profile of a derivatized plasma extract containing 68 nmol of cortisol per liter.
The standard curve was constructed by plotting the peakheight ratio for m/z 637/640 vs known cortisol concentration (Figure 3 ). Because cortisol contributes to the recording at m/z 640, the relationship is not linear. Therefore, the measured peak-height ratio for each standard concentration was conrected with a factor equal to: which was used tocalculate a correction factor, and in turn a corrected peak-height ratio. This sequencewas repeatedfive timesby useofa simpleBASIC program, after which thesixth digit didnotchange,and thecalculated cortisol concentration was takenastheanalytical result. The within-run precision ofthe GCMS method-.investigated for water, urine, and plasma samples-ranged between 2.5and 5.7% (Table1). Bj#{246}rkhem etal. (3) reported a relative standarddeviation(CV) of 3.5% fortheirmethod. For the estimationof day-to-dayvariation identical samples were taken from a plasma pooland analyzedwith each new standard curve. The mean cortisol concentration ofthepoo1was found tobe 157.9(SD 7.3)nmol/L (n = 29), CV 4.6%.
In theradioimmunoassaythewithin-run precision, as de-2. termined by duplicate analysis, in the range 110-663 nmol/L was 4.3%. Day-to-day variation was assessed by determining two plasma pools for each new standard curve. The mean cortisol concentrations were found to be 110 (SD 5.0) mnol/L (n 10) and 594 (SD 27.1) nmol/L (n = 10), with CVs of 4.5% and 4.6%, respectively. That study, however, was performed with a kit from New England Nuclear, which differs considerably from the kit used in our investigation (0. Lantto, personal communication)
and the results should not be compared. In the same paper (6), RIANEN was shown togivelowervalues thanGCMS atcortisol concentrations below about 150 nmol/L and higher values than GCMS above that value. In the present investigation such a trend was not seen. For only 11 of 395 samples was a higher concentration found with GCMS than with RIA.
A t -test of log(RIA/GCMS)
showed highly significant dif- The line y = x Is shown, for comparison two methods cannot be explained by cross reaction of the RIA method with synthetic glucocorticoids absorbed through the skin, because this possible interference was investigated and found to be insignificant for the low concentrations expected in plasma. The higher RIA values compared to GCMS probably reflect interferences with cortisol metabolites and other endogenous steroids (7). Accordingtotheinstruction manual from New England Nuclear the cross reaction against corticosterone is 25% (normal value for male subjects 11.4 6.6 nmol/L (8)1 and 11-deoxycortisol 12% [normal range 1.4-34.7 nmol/L (9)].
Lantto et al. (6) noted that when standards supplied with a RIA kit were used for calibration, falsely high cortisol values were found for authentic plasma samples. They ascribed this effect to the absence of an intact biological matrix in the standards. It is possible that a similar matrix effect has contributed to the high RIA values in this investigation.
We thank Dr. C. J. Lamm for valuable discussions concerning the statistical evaluation of the results.
were compared and evaluated by replicate and analytical recovery studies. I andII were about 50% more precise thanIll andIV. II was substantially more nearly accurate than the other methods and also gave the best reproducibility (correlation coefficient 0.992 between-day). The least expensive method was IV. Easeof handling favored I andII. Overall,we find II to be the most acceptable procedure foruse inthe clinical laboratory.
AddItIonalKeyphrases: drug assay . economics of laboratory operation
The therapeutic usefulness of tobramycin is tempered by its potential for ototoxicity (1, 2) and nephrotoxicity (3). Several factors influencing its toxicity and therapeutic response have been identified (4) . Therapeutic concentrations in serum range from 4 to 10 mgfL, with toxic symptoms when University of Oklahoma Health Sciences Center, Oklahoma City, OK 73190. peak serum concentrations exceed 10 mgfL and caution advised when trough values remain above 2 mg/L (5, 6). Because the therapeutic index of tobramycin is narrow and many factors may influence toxicity and therapeutic response, careful and frequent monitoring of the drug's concentrations in serum has been advocated, especially in the case of patients with renal insufficiency (3). The many assay methods for measuring tobramycin in serum are discussed in recent reviews (3, 7) of serum aminoglycoside measurement techniques.
BA (8) , RIA (9), EIA (10-12), and FIA (7, 13) seem to have found the widest acceptance among clinical laboratories.2 Here, we compare these methods on the basis of precision, accuracy, reproducibility, cost, and ease of handling.
Materials and Methods
Tobramycin controls used with each assay technique in- The technique of the bioassay method is described else-
